|
US4258051A
(en)
*
|
1975-01-10 |
1981-03-24 |
Research Corporation |
Method of treating viral infections
|
|
JPS6041077B2
(ja)
*
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
１，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
|
|
US4440782A
(en)
*
|
1977-03-01 |
1984-04-03 |
Research Corporation |
Method of treating viral infections
|
|
US4225529A
(en)
*
|
1977-10-19 |
1980-09-30 |
Johnson, Matthey & Co., Limited |
Compositions containing platinum
|
|
US4203912A
(en)
*
|
1977-10-19 |
1980-05-20 |
Johnson, Matthey & Co., Limited |
Compositions containing platinum
|
|
SE447385B
(sv)
*
|
1977-10-19 |
1986-11-10 |
Johnson Matthey Co Ltd |
Cis-koordinationsforeningar av platina
|
|
SE7903361L
(sv)
*
|
1978-04-20 |
1979-10-21 |
Johnson Matthey Co Ltd |
Kompositioner innehallande platina
|
|
GB2019405A
(en)
*
|
1978-04-20 |
1979-10-31 |
Johnson Matthey & Co Ltd Pt |
Pt (II) and (IV) Amino-Acid Complexes
|
|
SE7903359L
(sv)
*
|
1978-04-20 |
1979-10-21 |
Johnson Matthey Co Ltd |
Kompositioner innehallande platina
|
|
JPS6034958B2
(ja)
*
|
1978-09-02 |
1985-08-12 |
喜徳 喜谷 |
新規白金錯体
|
|
US4291027A
(en)
*
|
1979-03-07 |
1981-09-22 |
Engelhard Minerals & Chemicals Corp. |
Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
|
|
US4234500A
(en)
*
|
1979-03-07 |
1980-11-18 |
Engelhard Minerals & Chemicals Corporation |
Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
|
|
US4271085A
(en)
*
|
1979-06-20 |
1981-06-02 |
Engelhard Minerals & Chemicals Corporation |
Cis-platinum (II) amine lactate complexes
|
|
US4457926A
(en)
*
|
1979-06-20 |
1984-07-03 |
Engelhard Corporation |
Cis-Platinum(II) amine ascorbate complexes
|
|
US4505928A
(en)
*
|
1979-06-20 |
1985-03-19 |
Engelhard Corporation |
Pharmaceutical composition containing cis-platinum (II) amine lactate and a method of using same
|
|
US4462998A
(en)
*
|
1979-06-20 |
1984-07-31 |
Engelhard Corporation |
Method of using a cis-platinum(II) amine ascorbate
|
|
US4284579A
(en)
*
|
1979-07-17 |
1981-08-18 |
The United States Of America As Represented By The Of The Department Of Health & Human Services |
(N-Phosphonacetyl-L-aspartato)(1,2-diaminocyclchexane)platinum(II) or alkali metal salt
|
|
ZA805101B
(en)
*
|
1979-08-23 |
1981-08-26 |
Johnson Matthey Co Ltd |
Compositions containing platinium
|
|
NL181434C
(nl)
*
|
1980-01-03 |
1987-08-17 |
Tno |
Platina(iv)-diamine-complexen, alsmede hun bereiding en toepassing.
|
|
GR75598B
(ru)
*
|
1980-04-29 |
1984-08-01 |
Sanofi Sa |
|
|
JPS56154493A
(en)
*
|
1980-04-30 |
1981-11-30 |
Shionogi & Co Ltd |
Novel platinum complex
|
|
NZ197104A
(en)
*
|
1980-05-27 |
1984-05-31 |
Bristol Myers Co |
Soluble ammonium and sodium salts of 2-hydroxymalonato platinum ii derivatives
|
|
US4322362A
(en)
*
|
1980-07-28 |
1982-03-30 |
Bristol-Myers Company |
Salts of 2-hydroxymalonate platinum complexes
|
|
US4428943A
(en)
|
1980-06-09 |
1984-01-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
(N-Phosphonacetyl-L-aspartato) (1,2-diaminocyclohexane)platinum(II) or alkali metal salt
|
|
JPS5851959B2
(ja)
*
|
1980-06-11 |
1983-11-19 |
呉羽化学工業株式会社 |
プラチナ化合物とその医薬組成物
|
|
JPS5716895A
(en)
*
|
1980-07-05 |
1982-01-28 |
Otsuka Chem Co Ltd |
Platinum 2 complex and antitumor agent containing the same as active principle
|
|
JPS57123198A
(en)
*
|
1981-01-23 |
1982-07-31 |
Shionogi & Co Ltd |
Novel platinum complex
|
|
JPS5896024A
(ja)
*
|
1981-10-16 |
1983-06-07 |
リチヤ−ド・エフ・ストツケル |
白金毒解毒剤
|
|
US4500465A
(en)
*
|
1982-06-28 |
1985-02-19 |
Engelhard Corporation |
Solubilized platinum (II) complexes
|
|
US4584392A
(en)
*
|
1982-11-10 |
1986-04-22 |
Inco Alloys International, Inc. |
Platinum and palladium complexes
|
|
US4560782A
(en)
*
|
1982-11-19 |
1985-12-24 |
Research Corporation |
Anti-tumor diplatinum coordination compounds
|
|
IL67789A
(en)
*
|
1983-01-31 |
1986-09-30 |
Yissum Res Dev Co |
Amino-substituted malonato platinum(ii)complexes and method for their preparation
|
|
US4533502A
(en)
*
|
1983-02-22 |
1985-08-06 |
Rochon Fernande D |
Platinum (II) compounds and their preparation
|
|
US4906646A
(en)
*
|
1983-03-31 |
1990-03-06 |
Board Of Governors Of Wayne State University |
Method and composition for the treatment of tumors by administering a platinum coordination compound and a calcium channel blocker compound of the dihydropyridine class
|
|
US4617189A
(en)
*
|
1983-04-14 |
1986-10-14 |
Stockel Richard F |
Use of selenium-containing compounds for negating the toxic effects of platinum compounds used in chemotherapy, and a novel selenium-containing platinum compound and use thereof as an anti-cancer medicine
|
|
JPS59222498A
(ja)
*
|
1983-06-01 |
1984-12-14 |
Shionogi & Co Ltd |
新規グリコ−ル酸系白金錯体および抗悪性腫瘍剤
|
|
US4661516A
(en)
*
|
1983-06-20 |
1987-04-28 |
Research Corporation |
Diaminocyclohexane platinum complexes
|
|
US4758588A
(en)
*
|
1983-06-20 |
1988-07-19 |
Research Corporation Technologies |
Diaminocyclohexane platinum complexes
|
|
JPS6013795A
(ja)
*
|
1983-06-20 |
1985-01-24 |
リサ−チ・コ−ポレイシヨン |
ジアミノシクロヘキサン白金錯体
|
|
US4710577A
(en)
*
|
1983-08-05 |
1987-12-01 |
Yoshinori Kidani |
Cytostatic platinum organic complexes
|
|
GB8328218D0
(en)
*
|
1983-10-21 |
1983-11-23 |
Johnson Matthey Plc |
Oral compositions
|
|
DE3490640C2
(de)
*
|
1984-01-23 |
1990-04-19 |
Inst Obschei I Neoorganichesko |
Platin (II)-Carboxylatokomplexe und Verfahren zu ihrer Herstellung
|
|
US4843161A
(en)
*
|
1984-06-01 |
1989-06-27 |
Massachusetts Institute Of Technology |
Platinum-intercalative complexes for the treatment of cancer
|
|
GB8416048D0
(en)
*
|
1984-06-22 |
1984-07-25 |
Johnson Matthey Plc |
Anti-tumour compounds of platinum
|
|
EP0169645A1
(en)
*
|
1984-06-27 |
1986-01-29 |
Johnson Matthey Public Limited Company |
Platinum co-ordination compounds
|
|
US4645661A
(en)
*
|
1984-06-29 |
1987-02-24 |
St. Jude Children's Research Hospital |
Method for alleviating cisplatin-induced nephrotoxicity and dithiocarbamate compounds for effecting same
|
|
DK500185A
(da)
*
|
1984-11-02 |
1986-05-03 |
Johnson Matthey Plc |
Oploeseliggjort platinforbindelse
|
|
US4588831A
(en)
*
|
1984-11-09 |
1986-05-13 |
Natec |
Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use
|
|
US4665210A
(en)
*
|
1984-12-17 |
1987-05-12 |
American Cyanamid Company |
Platinum complexes of aliphatic tricarboxylic acids
|
|
ZA86704B
(en)
*
|
1985-02-23 |
1986-10-29 |
Asta Werke Ag Chem Fab |
Tumor retarding(1-benzyl-ethylenediamine9-platin(ii)-complexes
|
|
CA1274529A
(en)
*
|
1985-09-05 |
1990-09-25 |
Federico Sampedro |
Platinum(ii) complexes of 1,1-cyclobutane- dicarboxylate and process for their production
|
|
US4658047A
(en)
*
|
1985-09-27 |
1987-04-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of preparing 1,2-diaminocyclohexane tetrachloro platinum (IV) isomers
|
|
US5117022A
(en)
*
|
1985-10-18 |
1992-05-26 |
The Board Of Regents, The University Of Texas System |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
|
US5384127A
(en)
*
|
1985-10-18 |
1995-01-24 |
Board Of Regents, The University Of Texas System |
Stable liposomal formulations of lipophilic platinum compounds
|
|
US5041581A
(en)
*
|
1985-10-18 |
1991-08-20 |
The University Of Texas System Board Of Regents |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
|
US4760157A
(en)
*
|
1986-01-31 |
1988-07-26 |
American Cyanamid Company |
(2,2,-bis(aminomethyl)-1,3-propanediol-N,N')platinum complexes
|
|
US4670458A
(en)
*
|
1986-01-31 |
1987-06-02 |
American Cyanamid Company |
Hydroxylated 1,2-diaminocyclohexane platinum complexes
|
|
CS269719B1
(en)
*
|
1986-12-29 |
1990-05-14 |
Kiss Frantisek |
Platinum cytostatic
|
|
US5393909A
(en)
*
|
1988-11-22 |
1995-02-28 |
Board Of Regents, The University Of Texas System |
Diamine platinum complexes as antitumor agents
|
|
US5434256A
(en)
*
|
1988-11-22 |
1995-07-18 |
Board Of Regents, The University Of Texas System |
Diamine platinum complexes as antitumor agents
|
|
US5041578A
(en)
*
|
1988-11-22 |
1991-08-20 |
Board Of Regents, The University Of Texas System |
Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
|
|
US6884418B1
(en)
*
|
1989-08-04 |
2005-04-26 |
Berlex Laboratories, Inc. |
Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
|
|
US5455270A
(en)
*
|
1993-08-11 |
1995-10-03 |
Bristol-Myers Squibb Co. |
Stabilized solutions of platinum(II) antitumor agents
|
|
AU5878294A
(en)
*
|
1994-02-07 |
1995-08-21 |
Kiss Laboratories S.R.O. |
Anti-tumour medical preparation on the basis of carboplatin and the method of its production
|
|
US5922689A
(en)
*
|
1995-09-11 |
1999-07-13 |
Unitech Pharmaceuticals, Inc. |
Cisplatin analogs for cancer treatment
|
|
JP3154399B2
(ja)
*
|
1996-07-04 |
2001-04-09 |
デビオファーム エス．アー． |
白金化合物の製造方法
|
|
US20040072889A1
(en)
*
|
1997-04-21 |
2004-04-15 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
|
|
CN1068002C
(zh)
*
|
1997-04-30 |
2001-07-04 |
中国科学院大连化学物理研究所 |
铂抗癌药物及合成
|
|
AU747599C
(en)
*
|
1998-04-03 |
2003-06-05 |
Ajinomoto Co., Inc. |
Antitumor agents
|
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
AU775373B2
(en)
|
1999-10-01 |
2004-07-29 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
AU1608801A
(en)
|
1999-11-15 |
2001-05-30 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
|
US6545010B2
(en)
*
|
2000-03-17 |
2003-04-08 |
Aventis Pharma S.A. |
Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
|
|
EP1313508B1
(en)
*
|
2000-06-30 |
2007-04-18 |
Eli Lilly And Company |
Combination containing an antifolate and methylmalonic acid lowering agent
|
|
DE10032256C2
(de)
*
|
2000-07-03 |
2003-06-05 |
Infineon Technologies Ag |
Chip-ID-Register-Anordnung
|
|
TWI315982B
(en)
|
2001-07-19 |
2009-10-21 |
Novartis Ag |
Combinations comprising epothilones and pharmaceutical uses thereof
|
|
WO2003026581A2
(en)
*
|
2001-09-26 |
2003-04-03 |
Intermune, Inc. |
Pharmaceutical compositions and methods for treating cancer
|
|
US7038071B2
(en)
*
|
2002-07-16 |
2006-05-02 |
Sonus Pharmaceuticals, Inc. |
Platinum compounds
|
|
US7160908B2
(en)
*
|
2003-03-04 |
2007-01-09 |
Unitech Pharmaceuticals, Inc. |
Dynamic anticancer platinum compounds
|
|
CA2560059A1
(en)
*
|
2004-03-15 |
2005-09-29 |
Sonus Pharmaceuticals, Inc. |
Platinum carboxylate anticancer compounds
|
|
AU2006207321B2
(en)
|
2005-01-21 |
2012-09-06 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
WO2006103691A1
(en)
*
|
2005-03-28 |
2006-10-05 |
Dabur Pharma Ltd. |
Stable pharmaceutical compositions of platinum (ii) antitumour agents
|
|
JP2009536180A
(ja)
|
2006-05-09 |
2009-10-08 |
ノバルティス アクチエンゲゼルシャフト |
鉄キレート剤と抗新生物剤を含む組合せ剤およびそれらの使用
|
|
JP5528807B2
(ja)
|
2006-10-12 |
2014-06-25 |
アステックス、セラピューティックス、リミテッド |
複合薬剤
|
|
JP5528806B2
(ja)
|
2006-10-12 |
2014-06-25 |
アステックス、セラピューティックス、リミテッド |
複合薬剤
|
|
EP2061814B1
(en)
|
2006-10-27 |
2012-06-06 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
CA2705152C
(en)
|
2007-11-09 |
2016-10-11 |
Peregrine Pharmaceuticals, Inc. |
Anti-vegf antibody compositions and methods
|
|
EP2644204B1
(en)
|
2008-03-18 |
2017-04-19 |
Genentech, Inc. |
Combinations of an Anti-HER2 antibody-drug conjugate and pertuzumab
|
|
CA2719202A1
(en)
|
2008-03-27 |
2009-10-01 |
Taiho Pharmaceutical Co., Ltd. |
Anti-tumor agent comprising cytidine derivative and carboplatin
|
|
JP4664424B2
(ja)
|
2008-09-03 |
2011-04-06 |
ユニーテック株式会社 |
白金錯体及びそれを含む医薬組成物
|
|
WO2010104035A1
(ja)
|
2009-03-12 |
2010-09-16 |
学校法人近畿大学 |
非小細胞肺癌に対する化学療法の治療効果予測方法
|
|
CN103635192B
(zh)
|
2011-04-01 |
2017-07-04 |
基因泰克公司 |
Akt抑制剂化合物和化疗剂的组合以及使用方法
|
|
EP2508525A1
(en)
|
2011-04-05 |
2012-10-10 |
Bayer Pharma Aktiengesellschaft |
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
|
|
JP5179628B2
(ja)
|
2011-07-15 |
2013-04-10 |
ユニーテック株式会社 |
４価白金錯体及びそれを含む医薬組成物
|
|
EP3545968A1
(en)
|
2012-06-08 |
2019-10-02 |
F. Hoffmann-La Roche AG |
Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
|
|
PL3386997T3
(pl)
|
2015-12-09 |
2021-12-13 |
Medizinische Universität Wien |
Funkcjonalizowane monomaleimidem związki platyny do terapii nowotworowej
|
|
WO2017192290A1
(en)
|
2016-05-04 |
2017-11-09 |
The Wistar Institute Of Anatomy And Biology |
Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs
|
|
CN107773556B
(zh)
*
|
2016-08-26 |
2020-08-18 |
广州安好医药科技有限公司 |
一种具有抗肿瘤药物功效的联合用药物
|
|
SG11201909218RA
(en)
|
2017-04-03 |
2019-11-28 |
Hoffmann La Roche |
Antibodies binding to steap-1
|